OR10J2P

Across TCGA pan-cancer cohorts, OR10J2P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR10J2P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR10J2P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated OR10J2P expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

HNSC, BLCA, and LUSC are the cancer types where OR10J2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	1.000	0.685	.004	117	view →
BLCA	DFS	Tertile	IV	0.087	0.480	<.001	87	view →
LUSC	OS	Tertile	II,III,IV	0.080	0.733	<.001	81	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCEC	DFS	Tertile	All	0.702	0.846	.006	18	view →
LGG	DFS	Tertile	All	0.164	0.757	<.001	18	view →
OV	DFS	Tertile	All	0.735	0.533	.049	12	view →
PRAD	OS	Tertile	All	0.957	0.995	.007	12	view →
LAML	DFS	Tertile	All	0.224	0.444	.046	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THYM	DFS	Tertile	All	0.563	0.910	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR10J2P–HNSC (DFS)

Open the HNSC breakdown →